Industry News

These links are provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Global Excel of any of the products, services, or opinions of the corporation, organization, or individual. Global Excel bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.

The FDA's accelerated approval process, which allows pharmaceutical companies to license treatments without proving they are effective, has become a common path to market — accounting for 14 of the 50 approvals of novel drugs in 2021 compared with four among 59 in 2018: https://khn.org/news/article/pharma-fda-drugs-accelerated-approval-marginally-effective-expensive/...

Other members of the Global Excel family
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×